Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;3(1):121-5.
doi: 10.5681/apb.2013.020. Epub 2013 Feb 7.

Comparison of in Vitro Activity of Doripenem versus Old Carbapenems against Pseudomonas Aeruginosa Clinical Isolates from both CF and Burn Patients

Zoya Hojabri  1 , Mohammad Ahangarzadeh Rezaee, Mohammad Reza Nahaei, Mohammad Hossein Soroush, Morteza Ghojazadeh, Tahereh Pirzadeh, Mostafa Davodi, Mona Ghazi, Reza Bigverdi, Omid Pajand, Mohammad Aghazadeh
Affiliations

Comparison of in Vitro Activity of Doripenem versus Old Carbapenems against Pseudomonas Aeruginosa Clinical Isolates from both CF and Burn Patients

Zoya Hojabri et al. Adv Pharm Bull. 2013.

Abstract

Purpose: The antimicrobial activity of doripenem in comparison of imipenem, meropenem and ertapenem among Pseudomonas aeruginosa isolated from burn and Cystic Fibrosis (CF) patients were determined.

Methods: Metallo-β-lactamase (MBL) genes in imipenem non susceptible P. aeruginosa isolates were detected using PCR method. The in vitro susceptibilities of doripenem, imipenem, meropenem and ertapenem were determined by Etests. MIC50 and MIC90 for corresponding antibiotics were determined individually in burn and CF isolates.

Results: Among isolates which were resistant to imipenem, 16 isolates were positive for the bla IMP gene. All isolates had no bla VIM gene. All MBL producing isolates were excluded. MIC50/MIC90 of doripenem in CF and burn isolates were 0.75/>32 and >32/>32 mg/L respectively. The corresponding values for imipenem in CF and burn isolates were 2/>32 and >32/>32 mg/L, respectively.

Conclusion: The susceptibility rate of doripenem is higher than that of imipenem and meropenem among P.aeruginosa isolated from CF patients, whereas, there is no difference between the efficiency of doripenem and old carbapenems in non MBL producing P.aeruginosa isolates in burn patients.

Keywords: Burn; Cystic fibrosis; Doripenem; Imipenem; Iran; Pseudomonas aeruginosa.

PubMed Disclaimer

References

    1. Nomura S, Nagayama A. In vitro antibacterial activity of s-4661, a new parenteral carbapenem, against urological pathogens isolated from patients with complicated urinary tract infections. J Chemother. 2002;14(2):155–60. - PubMed
    1. Ohba F, Nakamura-Kamijo M, Watanabe N, Katsu K. In vitro and in vivo antibacterial activities of er-35786, a new antipseudomonal carbapenem. Antimicrob Agents Chemother. 1997;41(2):298–307. - PMC - PubMed
    1. Watanabe A, Takahashi H, Kikuchi T, Kobayashi T, Gomi K, Fujimura S. et al. Comparative in vitro activity of s-4661, a new parenteral carbapenem, and other antimicrobial agents against respiratory pathogens. Chemotherapy. 2000;46(3):184–7. - PubMed
    1. Parkins MD, Elborn JS. Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management. J Antimicrob Chemother. 2010;65(9):1853–61. - PubMed
    1. Lascols C, Legrand P, Merens A, Leclercq R, Armand-Lefevre L, Drugeon HB. et al. In vitro antibacterial activity of doripenem against clinical isolates from french teaching hospitals: Proposition of zone diameter breakpoints. Eur J Clin Microbiol Infect Dis. 2011;30(4):475–82. - PubMed

LinkOut - more resources